AMSERV HEALTHCARE INC
NT 10-K, 1995-09-22
HELP SUPPLY SERVICES
Previous: OKLAHOMA GAS & ELECTRIC CO, S-4/A, 1995-09-22
Next: MORTGAGE & REALTY TRUST, PRE 14C, 1995-09-22



<PAGE>
 
                                                            
                    U.S. SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549
                                                            
                                  FORM 12b-25
                                                           
                          NOTIFICATION OF LATE FILING
                                 (Check One):

     [X] Form 10-K  [_] Form 20-F  [_] Form 11-K [_] Form 10-Q [_] Form N-SAR
     For Period Ended:       June 24, 1995
                      ------------------------------------  
     [_]  Transition Report on Form 10-K
     [_]  Transition Report on Form 20-F         
     [_]  Transition Report on Form 11-K                    
     [_]  Transition Report on Form 10-Q                    
     [_]  Transition Report on Form N-SAR

     For the Transition Period Ended:
                                     -------------------------------------------

--------------------------------------------------------------------------------

     Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.

     Nothing in this form shall be construed to imply that the Commission has 
verified any information contained herein.

-------------------------------------------------------------------------------

     If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:__________N/A____________
________________________________________________________________________________

--------------------------------------------------------------------------------

PART I--REGISTRANT INFORMATION
--------------------------------------------------------------------------------

     AMSERV HEALTHCARE INC.
     3252 Holiday Court, Suite 204
     La Jolla, California 92037

--------------------------------------------------------------------------------

PART II--RULES 12b-25 (b) AND (c)

--------------------------------------------------------------------------------

If the subject report could not be filed without unreasonable effort or expense 
and the registrant seeks relief pursuant to Rule 12b-25(b), the following 
should be completed.  (Check box if appropriate)

     (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;

     (b) The subject annual report, semi-annual report, transition report
on Form 10-K, Form 20-F, 11-K, or Form N-SAR, or portion thereof will be filed
on or before the fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and

     (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.

------------------------------------------------------------------------------- 

<PAGE>
 
--------------------------------------------------------------------------------

PART III--NARRATIVE
--------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR or the transition report or portion thereof could not be filed within the 
prescribed time period.

                                                 (Attach Extra Sheets if Needed)
--------------------------------------------------------------------------------
AMSERV HEALTHCARE INC., by filing this Form 12(b)-25, is requesting an extension
of 15 days, until October 9, 1995, for the filing of Form 10-K pursuant to 
section 13 or 15(d) of the Securities Exchange Act of 1934. The Company is 
unable to file Form 10-K on the prescribed due date of September 22, 1995, due 
to the Company's chief executive officer's temporary absence due to unexpected 
surgery.

--------------------------------------------------------------------------------

PART IV--OTHER INFORMATION

     (1) Name and telephone number of person to contact in regard to this 
notification

    Lori Anderson                              (619)         597-1000
--------------------------------------------------------------------------------
         (Name)                             (Area Code)   (Telephone Number)

     (2) Have all other periodic reports required under section 13 or 15(d) of 
the Securities Exchange Act of 1934 or section 30 of the Investment Company Act 
of 1940 during the preceding 12 months or for such shorter period that the 
registrant was required to file such report(s) been filed? If the answer is no, 
indentify report(s).

                                                            [X] Yes    [_] No

     (3) Is it anticipated that any significant change in results of operations 
from the corresponding period for the last fiscal year will be reflected by the 
earnings statements to be included in the subject report or portion thereof?

                                                            [_] Yes    [X] No

     If so; attach an explanation of the anticipated change, both narratively 
and quantitatively, and, if appropriate, state the reasons why a reasonable 
estimate of the results cannot be made.

                            AMSERV HEALTHCARE INC.
--------------------------------------------------------------------------------
                 (Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned 
thereunto duly authorized.

Date: September 20, 1995            By: /s/ Lori Anderson
     -------------------------         -----------------------------------------

INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person 
signing the form shall be typed or printed beneath the signature. If the 
statement is signed on behalf of the registrant by an authorized representative 
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
--------------------------------------------------------------------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission